AI Solutions
Radiation Oncology
- Radiation Oncology
Zero click AI workflows for high-precision radiotherapy. In clinical use across Europe and US with up to 90% time saving for dosimetrists, RTTs and radiation oncologists.
ART-Plan™ is a web-browser based, scalable and modular AI automation platform for radiotherapy. Current modules include:
Annotate™: AI-powered software that provides fully automatic delineation of 150+ CT and MRI-based organs at risk (OARs) and lymph nodes from Simulator-to-TPS within 2-3 minutes and with the same accuracy as clinical experts, utilizing latest consensus contouring guidelines.
MR-Box™: Generates MRI-based pseudo-CT (conventional MRIs and MR linacs) for MR-only and MR guided radiotherapy to avoid registration errors, cost saving and improved patient comfort. Compatible standard MRIs and with Annotate for auto-contouring of OARs & lymph nodes.
SmartFuse™: The first AI-powered software for high-precision rigid and elastic fusion, that includes the management of 4D-CT and a real-time deformation of contours for faster replanning.
AdaptBox™ *: Provides decision making support using customisable objective metrics for adaptive radiotherapy by utilizing AI to generate an enhanced and augmented pseudo-CT from CBCT with a CT-like FOV, expert like contours using AI auto-contouring as well as re-calculating and comparing dose metrics to the active treatment plan.
IT deployment: The ART-Plan AI automation platform is web-browser based and can be deployed via cloud or locally as per IT preference.
* Not yet available for sale. Commercial launch est. for 2023.
We often see implementation of AI workflows being overcomplicated
- Comparing auto-contouring vs. gold standard clinical contours When assessing AI centers are often creating the perfect data sets for comparison, and often with overrepresentation of edge cases. AI should be evaluated up against the production output as AI are meant to support in every day clinical operation.
- No training program / education prior to and upon introducing automation TEXT FROM ANDRAS!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
- Creating vendor monopoly Radiation Oncology are dominated by very few large vendors, creating a high risk for vendor lock-in decreasing the procurement power of the center. By implementing zero click RT workflows that runs in the background of existing TPS systems, not all eggs are laid in the basket of one single large vendor.
Clinical evidence
https://www.therapanacea.eu/resources/publications/
TheraPanacea is a serial award-winning medical technology company founded in 2017 harnessing AI to develop cutting-edge software for more efficient and precise cancer care. Their radiotherapy AI automation platform ART-Plan™ has been CE-marked in 2019 (FDA clearance, etc. followed soon) and since then ART-Plan is already in use across Europe and US.
- In use in 70 radiotherapy departments across Europe and world-wide.
- 1 out of 4 radiotherapy patients in France is being auto-contoured with TheraPanacea’s ART-Plan
- 150,000 patient cases are being auto-contoured per year with ART-Plan world-wide